BioLexa

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa platform. What Happened: New York-based Hoth says data from the Cohort 1 of a two-part, Phase 1b study of BioLexa...